APA način citiranja

Kus, T., Aktas, G., Kalender, M. E., Demiryurek, A. T., Ulasli, M., Oztuzcu, S., . . . Camci, C. (2016). Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel. Onco Targets Ther.

Čikaški stil citiranja

Kus, Tulay, Gokmen Aktas, Mehmet Emin Kalender, Abdullah Tuncay Demiryurek, Mustafa Ulasli, Serdar Oztuzcu, Alper Sevinc, Seval Kul, i Celaletdin Camci. "Polymorphism of CYP3A4 and ABCB1 Genes Increase the Risk of Neuropathy in Breast Cancer Patients Treated With Paclitaxel and Docetaxel." Onco Targets Ther 2016.

MLA način citiranja

Kus, Tulay, et al. "Polymorphism of CYP3A4 and ABCB1 Genes Increase the Risk of Neuropathy in Breast Cancer Patients Treated With Paclitaxel and Docetaxel." Onco Targets Ther 2016.